RB
Rajendra Balaso Patil
About Rajendra Balaso Patil
Data last updated:
Rajendra Balaso Patil has 7 years in corporate governance. Holds Designated Partner and Partner roles. Currently with 2 companies, including Innovlife Pharma Llp and Klerix Pharma Llp. Formerly with 1 company, such as Aqutex Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Innovlife Pharma Llp ACL-4685 | Designated Partner | 22 Jan 2025 | 2025 | – | Active |
| Klerix Pharma Llp AAO-3919 | Partner | 27 Feb 2019 | 2019 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Aqutex Pharma Private Limited U21001PN2023PTC223207 | Director | 18 Aug 2023 | 2023 | – | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajendra Balaso Patil
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajendra Balaso Patil
Rajendra Balaso Patil has 7 years in corporate governance. Holds Designated Partner and Partner roles. Currently with 2 companies, including Innovlife Pharma Llp and Klerix Pharma Llp. Formerly with 1 company, such as Aqutex Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.
Rajendra Balaso Patil is associated with 2 companies as Designated Partner and Partner, including Innovlife Pharma Llp, Klerix Pharma Llp.
Rajendra Balaso Patil has expertise in General Business.
Rajendra Balaso Patil has 7 years in corporate governance.
Rajendra Balaso Patil currently holds positions at 2 companies: Innovlife Pharma Llp, Klerix Pharma Llp.